During the past decade, MHAT Targovishte AD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 10 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MHAT Targovishte AD" #1 sponsor was "Sunovion" with 3 trials, followed by "EMD Serono" with 2 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "AbbVie" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "MHAT Targovishte AD" are "Depressive Disorder, Major" (3 trials), "Schizophrenia" (3 trials), "Lupus Erythematosus, Systemic" (2 trials), "Arthritis, Psoriatic" (1 trials) and "Autism" (1 trials). Many other conditions were trialed in "MHAT Targovishte AD" in a lesser frequency.

Most popular intervention types in "MHAT Targovishte AD" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Atacicept 150 mg" (2 trials), "Cariprazine" (2 trials), "Vortioxetine" (2 trials) and "Atacicept 75 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Targovishte AD" are 11 trials for "All" genders.

Currently, there are NaN active trials in "MHAT Targovishte AD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in MHAT Targovishte AD, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Targovishte AD, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".